Wolfe Laboratories - GLP Toxicology Studies

>	CASE STUDY 1 Parenteral dosage form development of a highly insoluble molecule
>	CASE STUDY 2 Salt form optimization and lyophilized parenteral formulation development
>	CASE STUDY 3 Oral liquid formulation development
>	CASE STUDY 4 Accelerated stability studies to support a screening IND
>	CASE STUDY 5 Lead Optimization: Solubility and formulation screen for efficacy and PK studies

Support of GLP Toxicology Studies Now Available

Wolfe Laboratories, Inc. now provides test article characterization to support GLP toxicology studies. Building on over five years of providing high-quality pharmaceutical development services, we have added the personnel and processes to meet appropriate regulatory compliance for our clients. WLI has instituted appropriate laboratory practices consistent with standard laboratory data recording and documentation practices to assist our clients in meeting the intent of the GLP regulations. WLI's practices to support GLP toxicology studies address:

Soundness, traceability and security of raw data
Qualifications of personnel
Quality assurance function and processes
Adequacy of facilities and equipment
Standard operating procedures
Test and control articles
Conduct of studies
Reporting of results
Recording of storage and retention

For more information, please contact info@wolfelabs.com.